About Rossari Biotech Limited

Rossari Biotech Limited, established in 1997 and headquartered in Mumbai, is a leading specialty chemicals company in India with a diverse portfolio of over 4,300 products. The company provides sustainable, high-performance solutions for industries such as FMCG, home and personal care, industrial cleaning, textiles, animal health, and nutrition.

Rossari operates world-class manufacturing facilities in Silvassa and Dahej, with an aggregate capacity of 2,52,000 MTPA. It has built strong R&D capabilities to support continuous product innovation, sustainability, and customer-specific solutions. Over the years, Rossari has expanded into global markets, serving over 3,000 customers across 65+ countries.

The company functions as part of the Rossari Group, which also includes subsidiaries Unitop Chemicals Private Limited, Tristar Intermediates Private Limited, Buzil Rossari Private Limited, Rossari Consumer Products Private Limited, and Romakk Chemicals Private Limited. These entities enhance Rossari’s expertise in surfactants, perfumery and dye intermediates, hygiene products, pet care, and silicone-based chemicals, giving the group an integrated and diversified presence in specialty chemicals.

Rossari Biotech Limited’s Business Segments

Rossari operates under three main business divisions:

• Home, Personal Care & Performance Chemicals (HPPC): Offers surfactants, esters, preservatives, polymers, agro-chem ethoxylates, and hygiene products. Generated Rs 15,901 million revenue in FY 2024–25.
• Textile Specialty Chemicals (TSC): Provides eco-friendly solutions across the textile value chain, including fibre, yarn, fabric processing, dyeing auxiliaries, and garment finishing. Generated Rs 3,745 million revenue in FY 2024–25.
• Animal Health & Nutrition (AHN): Supplies poultry feed supplements, aqua additives, therapeutic formulations, and pet care products. Generated Rs 1,156 million revenue in FY 2024–25.

On a consolidated basis, Rossari reported revenue from operations of Rs 20,802.94 million in FY 2024–25, EBITDA of Rs 2,650.82 million, and PAT of Rs 1,363.78 million.

Rossari Biotech Limited’s Key Management

• Mr. Edward Menezes – Executive Chairman
• Mr. Sunil Chari – Managing Director
• Mr. Bharat Shetty – Partner, Walker Chandiok & Co LLP (Statutory Auditor)
• Mr. Ketan Sablok – Group Chief Financial Officer
• Ms. Parul Gupta – Head – Company Secretary & Legal

Latest Updates on Rossari Biotech Limited

• Financial Growth: Consolidated revenue rose to Rs 20,802.94 million in FY 2024–25 from Rs 18,305.58 million in FY 2023–24; PAT increased to Rs 1,363.78 million.
• Subsidiary Performance: Unitop Chemicals contributed Rs 7,737.78 million revenue; Tristar Rs 2,617.49 million; Buzil Rossari Rs 2,760.69 million; Rossari Consumer Rs 224.59 million; Romakk Chemicals Rs 323.41 million.
• Global Expansion: Acquired Unistar Thai Co. Ltd. to strengthen international presence; established a new company in UAE to enhance global trade.
• Capacity Expansion: Commissioned capex of Rs 1,780 million at Dahej to scale ethoxylation capacity and HPPC production.
• Innovation: Developed a next-gen single-component emulsifier for agrochemicals and expanded sustainable green chemistry solutions.
• Sustainability: Accelerated adoption of eco-friendly, biodegradable, and resource-efficient chemicals, earning certifications like ZDHC Level 3.1 and GOTS.
• Market Reach: Expanded operations in Bangladesh, Nepal, Sri Lanka, Egypt, and Thailand; strengthened textile and animal nutrition businesses internationally.
• Governance: Secretarial and statutory audits confirmed compliance with SEBI and Companies Act requirements, with no adverse remarks.